Health Library

Cancer Types - About Taxol

To search through our library of topics, please make a selection below. Remember, the information in this library does not substitute for the advice provided by your healthcare team. Always consult your physician for more information.

Cancer Types - About Taxol

What is Taxol™?

Taxol, or paclitaxel, is a drug used for treating certain women who have advanced breast or ovarian cancer. Paclitaxel is a compound that is extracted from the bark of the Pacific yew tree.

In December of 1992, the US Food and Drug Administration (FDA) approved Taxol for treatment of ovarian cancer that had not responded to standard chemotherapy. Subsequent clinical trials demonstrated that Taxol was also effective in treating advanced breast cancer. In April of 1994, the FDA approved Taxol for the treatment of metastatic breast cancer that did not respond to combination chemotherapy, or breast cancer that had recurred within 6 months after the completion of initial chemotherapy.

Taxol has now been approved for adjuvant treatment of breast cancer that has spread to the lymph nodes when given following a doxorubicin chemotherapy regimen.

Taxol is given as an infusion drip into the vein.

What are taxanes?

Taxanes are a group of medications used to treat breast cancer. Taxol is a taxane. Other taxanes include docetaxel (Taxotere®) and paclitaxel (Abraxane™).

Taxotere has been approved for treatment of locally advanced or metastatic breast cancer. Abraxane is approved for use in advanced or recurrent breast cancer. Abraxane is a new formulation of paclitaxel that can be given over thirty minutes as opposed to three hours for Taxol and there is less likelihood of an adverse reaction to the drug.

What are possible side effects of Taxol?

Women considering taking Taxol should consult their physician. Everyone experiences side effects differently. Side effects of Taxol (and taxanes) may include:

  • hair loss
  • numbness of the fingers and toes
  • neutropenia - a decrease in white blood cells which may increase the risk of infections
  • nausea and vomiting
  • headaches
  • mouth sores
  • aching or pain in joints and muscles
  • diarrhea
  • skin rash

According to the National Cancer Institute and the American Cancer Association, the risks associated with Taxol are believed to be outweighed by the benefits for persons with advanced breast cancer.

Research continues to evaluate the effectiveness of the Taxol as well as the development of a new semi-synthetic paclitaxel.

Click here to view the
Online Resources of Cancer Center

Connect with MLH

New Appointments
1.866.CALL.MLH

 Well Ahead Newsletter


Connect With MLH

Copyright 2014 Main Line Health

Printed from: www.mainlinehealth.org/diw/content.asp?PageID=P07359

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.